IRF7 and glioblastoma: This analysis confirmed and further elucidated context-specific networks that captured biologically relevant disease heterogeneity and revealed key regulators in the HSV-1 pathway—specifically STAT1, IRF7, and DDX58—generalizable to dsDNA-based oncolytic immunovirotherapy responses in GBM patients.